Ulcerative Colitis Treatment

A new drug could bring relief for the 250,000 Britons who have the serious bowel disorder Ulcerative Colitis Treatment disease.Vedolizumab is the first to work directly in the gut lining, targeting the inflammation that causes chronic symptoms such as diarrhoea, bleeding and fatigue.In trials, 40 per cent of patients were free of symptoms for at least a year – with healing of the gut lining in some cases.Vedolizumab is the biggest advance since drugs known as anti-TNFs were developed in the 1990s. Researchers at Barts Health NHS Trust say the new Ulcerative Colitis Treatment, a course of which costs about £12,000 a year, brings ‘additional options’.

The disease may be diagnosed at any age, but it tends to strike early in life.Sufferers have periods of good health as well as times when symptoms are more active, known as relapses or flare-ups.Trial data shows that 40 per cent of patients taking the new Ulcerative Colitis Treatment are free of symptoms for at least one year, with healing of the gut lining in some sufferers.

Prev1 of 2
Continue Reading on Next Page

Leave A Reply

error: Content is protected !!